ArticleAbdominal radiology (New York)2025
A novel artificial intelligence segmentation model for early diagnosis of bladder tumors.
Article in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A multicenter study of automatic segmentation-based multimodal fusion integrating radiomics, deep learning, and clinical parameters for prostate cancer detection.Abdominal radiology (New York) · 2026Article
- Artificial intelligence in urological malignancy diagnosis and prognosis: current status and future prospects.The Canadian journal of urology · 2026Review
- Beyond Visualization: Advanced Imaging, Theragnostics and Biomarker Integration in Urothelial Bladder Cancer.Cancers · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveDespite cystoscopy plays an important role in bladder tumors diagnosis, it often falls short in flat cancerous tissue and minuscule satellite lesions. It can easily lead to a missed diagnosis by the urologist, which can lead to a swift tumor regrowth following transurethral resection of the bladder tumor (TURBT). Therefore, we developed a deep learning-based intelligent diagnosis system for early bladder cancer to improve the identification rate of early bladder tumors.
methodsVideo data from 273 bladder cancer patients who underwent TURBT at Zhongnan Hospital were collected. The dataset was carefully annotated by urologists to clearly define tumor boundaries. Subsequently, we developed a new bladder tumor segmentation network (BTS-Net) based on transformer to accurately diagnose early-stage bladder cancer lesions.
resultsOur experiments demonstrate that the BTS-Net we developed has outperformed other method on the external B validation dataset, achieving a MPrecision of 91.39%, a MRecall of 95.71%, a MIoU of 88.18% and an F1-score of 93.18%. The BTS-Net showed high accuracy with real-time processing speed at 23 fps.
conclusionMissed detection of satellite lesions in early bladder tumors often leads to tumor recurrence. Our BTS-Net is capable of segmenting all potential satellite lesions in surgical videos, without the need for complex professional equipment. This AI-assisted diagnosis system has the potential to improve surgical outcomes by ensuring comprehensive treatment of all tumor-related areas during TURBT.
Indexed as
Identifiers
39738572What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.